Wallace Weitz Weitz Investment Management
Wallace Weitz founded Weitz Investment Management and built a long career as a patient, research-driven value investor. The firm is known for concentrated equity portfolios, conservative balance-sheet analysis, and multi-year holding periods. Weitz’s letters and process notes are frequently recommended to investors learning classic U.S. value management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$59.9M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$25.4M |
| 3 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$25.1M |
| 4 |
Labcorp
LH
|
+$22.1M |
| 5 |
Liberty Global Class C
LBTYK
|
+$16.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$79.3M |
| 2 |
OUTR
OUTERWALL INC
OUTR
|
+$37.9M |
| 3 |
Bausch Health
BHC
|
+$21.2M |
| 4 |
United Parcel Service
UPS
|
+$16M |
| 5 |
CVS Health
CVS
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Communication Services | 15.93% |
| 3 | Healthcare | 14.04% |
| 4 | Consumer Discretionary | 13.77% |
| 5 | Financials | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Compass Minerals
CMP
$1.09B
| $6.8M | 0.23% |
85,000
| – | – |
|
52
Prestige Consumer Healthcare
PBH
$2.43B
| $5.37M | 0.18% |
150,000
| – | – |
|
|
ASCMA
53
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $5.13M | 0.17% |
60,000
| – | – |
|
54
Willis Towers Watson
WTW
$31.8B
| $4.48M | 0.15% |
37,750
| – | – |
|
|
CCRD
55
DELISTED
CoreCard
CCRD
| $3.68M | 0.12% |
2,270,000
| – | – |
|
|
OUTR
56
DELISTED
OUTERWALL INC
OUTR
| $1.47M | 0.05% |
21,804
-581,362
| -96% | -$37.9M |
|
57
AB InBev
BUD
$155B
| $1.38M | 0.05% |
13,000
| – | – |
|
|
58
CVS Health
CVS
$119B
| $716K | 0.02% |
10,000
-191,860
| -95% | -$12.3M |
|
59
US Bancorp
USB
$96.7B
| $606K | 0.02% |
15,000
-5,000
| -25% | -$192K |
|
|
ESI
60
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $583K | 0.02% |
17,360
-5,600
| -24% | -$201K |
|
61
Apple
AAPL
$4.51T
| $449K | 0.02% |
22,400
| – | – |
|
|
OCR
62
DELISTED
OMNICARE INC
OCR
| – | – |
-113,700
| Closed | -$6.31M |
|
Similar funds
Wallace Weitz's Q4 2013 Portfolio in Review
As of Q4 2013, Wallace Weitz held 63 positions worth $2.98B, up 12% from $2.66B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Wallace Weitz's Q4 2013 filing shows 3 new, 23 increased, 20 reduced and 1 closed positions. Its largest new stake was Endo International plc: 445,920 shares worth $30.1M. The largest sale was Aon, an estimated $79.3M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Communication Services and Healthcare.
- Wallace Weitz's largest Q4 2013 buy was Endo International plc: 445,920 shares worth $30.1M.
- Wallace Weitz added most to Oracle in Q4 2013, an estimated $59.9M increase.
- Wallace Weitz's biggest Q4 2013 reduction was Aon, cutting an estimated $79.3M.
- Wallace Weitz fully exited OMNICARE INC in Q4 2013, selling an estimated $6.31M.
- Wallace Weitz's ten largest holdings make up 44% of its $2.98B portfolio in Q4 2013.
- Wallace Weitz opened 3 new positions and closed 1 in Q4 2013.
- Wallace Weitz's portfolio value rose 12% quarter-over-quarter to $2.98B.
Based on Weitz Investment Management's 13F filing for Q4 2013, filed 13 Feb 2014.